Endurant Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $11.3M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $14.2M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $12.5M | Buy |
|
|||||
|
2021
Q2 | $6.75M | Sell |
|
|||||
|
2021
Q1 | $14.8M | Sell |
|
|||||
|
2020
Q4 | $15.1M | Sell |
|
|||||
|
2020
Q3 | $23.5M | Buy |
|
|||||
|
2020
Q2 | $2.12M | Sell |
|
|||||
|
2020
Q1 | $7.63M | Sell |
|
|||||
|
2019
Q4 | $25.8M | Buy |
|
|||||
|
2019
Q3 | $14.8M | Buy |
|
|||||
|
2019
Q2 | $3.91M | Sell |
|
|||||
|
2019
Q1 | $13.9M | Buy |
|
|||||
|
2018
Q4 | $2.56M | Sell |
|
|||||
|
2018
Q3 | $4.84M | Buy |
|